Form 4: 2seventy bio Executive Jessica Snow Sells Shares to Cover Tax Obligations and Under 10b5-1 Plan
SEC Form 4 Filing
Jessica Snow, a Senior Vice President at 2seventy bio, sold shares of common stock to cover tax obligations and under a pre-arranged 10b5-1 trading plan.
Summary
- Jessica Snow, Senior Vice President of Quality and Enabling Functions at 2seventy bio, sold shares of the company's common stock.
- The sales occurred on January 3, 2025, January 6, 2025 and January 7, 2025.
- A total of 6,299 shares were sold across these dates.
- The sales were conducted to cover tax withholding obligations related to the vesting of restricted stock units and under a pre-arranged Rule 10b5-1 trading plan.
- Following these transactions, Jessica Snow directly owns 147,179 shares of 2seventy bio.
- The sales prices ranged from $2.63 to $3.01 per share.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports stock sales by an executive, which is a routine event. The sales were partly to cover tax obligations and partly under a pre-arranged trading plan, suggesting no particular concern about the company's prospects.
Industry Context
Executive stock sales are a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares without being accused of trading on non-public information. The market will likely interpret these sales in the context of the company's overall performance and future prospects.
Stakeholder Impact
- The stock sales could have a minor negative impact on shareholder sentiment, but the impact is likely to be minimal given the reasons for the sales and the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 09/13/2024 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| 01/03/2025 | Date of first reported transaction: Sale of 1,000 shares at a weighted average price of $2.9359. |
| 01/06/2025 | Date of second reported transaction: Sale of 114 shares at a weighted average price of $2.7785 and 5,000 shares at a weighted average price of $2.7944. |
| 01/07/2025 | Date of third reported transaction: Sale of 186 shares at an average price of $2.64. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.